Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.

@article{Hannan2008DrugelutingSV,
  title={Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.},
  author={E. Hannan and Chuntao Wu and G. Walford and A. Culliford and J. Gold and Craig R. Smith and R. Higgins and Russell E Carlson and R. Jones},
  journal={The New England journal of medicine},
  year={2008},
  volume={358 4},
  pages={
          331-41
        }
}
BACKGROUND Numerous studies have compared the outcomes of two competing interventions for multivessel coronary artery disease: coronary-artery bypass grafting (CABG) and coronary stenting. However, little information has become available since the introduction of drug-eluting stents. METHODS We identified patients with multivessel disease who received drug-eluting stents or underwent CABG in New York State between October 1, 2003, and December 31, 2004, and we compared adverse outcomes (death… Expand
Drug-eluting stents versus bypass surgery for multivessel coronary disease
TLDR
Focus is placed on the recent data and evidence for long-term outcomes in patients treated with DES or CABG for complex multivessel coronary disease, including unprotected left main disease. Expand
Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease: Three-Year Follow-Up Results From a Single Institution
TLDR
In a cohort of patients with multivessel disease, CABG was associated with lower rates of death, myocardial infarction, and target-vessel revascularization than drug-eluting stents in a 3-year follow-up. Expand
Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease.
TLDR
CABG might be associated with cost-effectiveness and could be still the first revascularization strategy for ULMCA disease in the era of drug-eluting stents. Expand
Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents.
TLDR
Bypass surgery is associated with lower risk of death than stenting with DES for multivessel disease without left main stenosis in patients with LAD artery disease but not in patients without L AD artery disease. Expand
Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
TLDR
Among patients with CKD and multivessel CAD, PCI with DES when compared with CABG resulted in similar rates of composite outcome of mortality from any cause, MI, or stroke; however, a higher risk of repeat revascularization was observed. Expand
Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
TLDR
Among patients with significant CAD and severe LV dysfunction, CABG showed a lower risk of all-cause death, cardiac- cause death, and repeat revascularization compared with PCI with drug-eluting stents, and was particularly pronounced in patients receiving β blockers and angiotensin-converting enzyme inhibitor or angiotENSin receptor blockers. Expand
Off-Pump Coronary Artery Bypass vs Percutaneous Coronary Intervention
TLDR
Current evidence from randomized trials, a meta-analysis and several observation studies are reviewed, and the comparative effectiveness of PCI and OPCAB remains uncertain. Expand
Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease
TLDR
Angiographic CR with drug-eluting stent implantation or coronary artery bypass grafting did not improve long-term clinical outcomes in patients with multivessel coronary disease, and this finding supports the strategy of ischemia-guided revascularization. Expand
Revascularization strategies for patients with stable coronary artery disease
TLDR
Improvements in both CABG and PCI mean that they will continue to challenge each other in the future and a ‘heart team’ approach is strongly recommended to select an evidence‐based, yet individualized, revascularization strategy for all patients with complex coronary artery disease. Expand
PCI versus CABG for multivessel coronary disease in diabetics
  • G. Tarantini, A. Ramondo, +8 authors S. Iliceto
  • Medicine
  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2009
TLDR
For patients with DM and MVD, a clinical judgment‐based revascularization by DES‐PCI is not associated with worse 2‐year outcome compared with CABG, when it is based on clinical judgment. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 38 REFERENCES
Long-term outcomes of coronary-artery bypass grafting versus stent implantation.
TLDR
For patients with two or more diseased coronary arteries, CABG is associated with higher adjusted rates of long-term survival than stenting. Expand
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
TLDR
In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed. Expand
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
TLDR
As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction, however, stenting is associated with a greater need for repeated revascularization. Expand
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.
TLDR
In this selected high-risk group of patients with multivessel disease, PTCR with stent implantation showed better survival and freedom from MI than did conventional surgery. Expand
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
TLDR
It is found that survival at 10 years was similar for CABG and PCI, even among diabetic patients, and the evidence from RCTs on the comparative effectiveness of PCI and CABGs was evaluated. Expand
Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial
TLDR
The use of coronary stents has reduced the need for repeat revascularisation when compared with previous studies that used balloon angioplasty, though the rate remains significantly higher than in patients managed with CABG. Expand
A Prospective Randomized Trial Comparing Stenting to Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery Stenosis: The SIMA Trial
TLDR
Both stent implantation and CABG are safe and highly effective treatments to relieve symptoms in patients with isolated, proximal left anterior descending coronary artery stenosis, and both are associated with a low and comparable incidence of death and myocardial infarction. Expand
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
TLDR
As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events. Expand
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
TLDR
The extended use of clopidogrel in patients with DES may be associated with a reduced risk for death and death or MI, and the appropriate duration for clopIDogrel administration can only be determined within the context of a large-scale randomized clinical trial. Expand
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.
  • P. Serruys, A. Ong, +10 authors Dennis J Donohoe
  • Medicine
  • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2005
TLDR
The low incidence of MACCE and repeat revascularisation in ARTS II suggests that contemporary PCI with sirolimus-eluting stents is safe and efficacious for the treatment of multivessel coronary artery disease. Expand
...
1
2
3
4
...